Canadian Psoriasis Guidelines Addendum Committee. 2016 addendum to the Canadian guidelines for the management of plaque psoriasis 2009. J Cutan Med Surg. 2016;20(5):375-431.doi:10.1177/120347541665570527421294
2.
MoustafaF.FeldmanSR. A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology. Dermatol Online J. 2014;20(5):22608.24852768
3.
SnapeSD.Wigger-AlbertiW.GoehringUM. A phase I randomized trial to assess the effect on skin infiltrate thickness and tolerability of topical phosphodiesterase inhibitors in the treatment of psoriasis vulgaris using a modified psoriasis plaque test. Br J Dermatol. 2016;175(3):479-486.doi:10.1111/bjd.1463427038440
4.
LebwohlMG.PappKA.Stein GoldLet al. Trial of roflumilast cream for chronic plaque psoriasis. N Engl J Med. 2020;383(3):229-239.doi:10.1056/NEJMoa200007332668113
5.
HashimPW.ChimaM.KimHJet al. Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: a double-blind, randomized, vehicle-controlled trial. J Am Acad Dermatol. 2020;82(2):360-365.doi:10.1016/j.jaad.2019.06.128831279028
